Vessel PlusPub Date : 2024-05-16DOI: 10.20517/2574-1209.2023.149
Yasmin A. Toy, Kayla N. House, Leslie M. Boyer, Jennifer L. McNamara, Marion A. Hofmann-Bowman, Kim A. Eagle, Michelle S Lim, Alan C. Braverman, Siddharth K. Prakash
{"title":"Multicenter randomized controlled trial of exercise in aortic dissection survivors: rationale, design, and initial hemodynamic data","authors":"Yasmin A. Toy, Kayla N. House, Leslie M. Boyer, Jennifer L. McNamara, Marion A. Hofmann-Bowman, Kim A. Eagle, Michelle S Lim, Alan C. Braverman, Siddharth K. Prakash","doi":"10.20517/2574-1209.2023.149","DOIUrl":"https://doi.org/10.20517/2574-1209.2023.149","url":null,"abstract":"Aims: There are currently no evidence-based guidelines for exercise after thoracic aortic dissection (TAD), leading to highly variable recommendations that frequently lead patients to restrict their physical activities. This multicenter randomized controlled trial was intended to evaluate the safety and efficacy of a moderate intensity guided exercise program for TAD survivors.\u0000 Methods: Participants were eligible if they had a Type A or Type B dissection at least 90 days before enrollment and could attend two in-person study visits. The guided exercise circuit consisted of six aerobic, isotonic, or isometric exercises that participants continued at home with virtual follow-up sessions. The primary endpoint is the change in the composite anxiety and depression PROMIS-29 T-score at 12 months. Secondary endpoints include changes in grip strength, weight, 24-h ambulatory blood pressure, and arterial biomechanical properties measured by central arterial waveform analysis.\u0000 Results: Preliminary analysis of the first 81 enrolled participants demonstrated that the guided exercise circuit was completed safely and was not associated with severe hypertension, injury, or adverse cardiovascular events. At enrollment, adverse central waveform or ABPM characteristics were prevalent and were significantly associated with exertional hypertension.\u0000 Conclusions: Guided exercise is safe for aortic dissection survivors. Follow-up of enrolled participants will conclude in October 2024.","PeriodicalId":509663,"journal":{"name":"Vessel Plus","volume":"17 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140969552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Vessel PlusPub Date : 2024-05-13DOI: 10.20517/2574-1209.2023.65
E. Rinaldi, D. Mascia, Carlo Campesi, Alessio Centi Pizzutilli, G. Melissano
{"title":"Endovascular repair for acute aortic syndrome involving the descending aorta","authors":"E. Rinaldi, D. Mascia, Carlo Campesi, Alessio Centi Pizzutilli, G. Melissano","doi":"10.20517/2574-1209.2023.65","DOIUrl":"https://doi.org/10.20517/2574-1209.2023.65","url":null,"abstract":"This review paper delves into the acute aortic syndromes, with a particular focus on those affecting the descending thoracic aorta, including acute type B aortic dissection (aTBAD), intramural hematoma (IMH), penetrating aortic ulcer (PAU), blunt traumatic thoracic aortic injury (bTAI), and ruptured aneurysm of the descending thoracic aorta (rDTA). These conditions present with sudden-onset symptoms such as severe chest or back pain, necessitating immediate medical attention. While traditional open surgical repair was historically the mainstay of treatment, advancements in endovascular techniques have revolutionized management approaches. Endovascular treatment offers advantages such as reduced operative time, blood loss, and hospital stay, making it a safer option for high-risk patients. However, it is crucial to carefully evaluate patients for endovascular suitability, considering the potential complications and risks associated with these techniques. This paper aims to provide an updated overview of acute aortic syndromes involving the descending thoracic aorta, analyze available therapeutic options, and review contemporary treatment modalities, shedding light on the technical aspects and considerations guiding clinical decision-making in this complex and life-threatening scenario.","PeriodicalId":509663,"journal":{"name":"Vessel Plus","volume":"115 28","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140985685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Vessel PlusPub Date : 2024-05-11DOI: 10.20517/2574-1209.2024.13
E. Bianchini, Francesco Bianchini, Mattia Lunardi, A. Zito, Enrico Romagnoli, C. Aurigemma, L. Paraggio, Ilaria Dato, F. Burzotta, C. Trani
{"title":"Outcomes, risk factors, and procedural management of acute myocardial infarction caused by stent thrombosis","authors":"E. Bianchini, Francesco Bianchini, Mattia Lunardi, A. Zito, Enrico Romagnoli, C. Aurigemma, L. Paraggio, Ilaria Dato, F. Burzotta, C. Trani","doi":"10.20517/2574-1209.2024.13","DOIUrl":"https://doi.org/10.20517/2574-1209.2024.13","url":null,"abstract":"Coronary stent thrombosis (ST) is a rare but severe complication of percutaneous coronary interventions (PCIs) with significant implications for patient outcomes. Despite advancements in antiplatelet medications and drug-eluting stent (DES) technology, ST remains associated with considerable morbidity and mortality. Notably, ST is an adverse event arising from various factors, including patient characteristics, stent-related issues, and procedural complications. In such a context, intravascular imaging (IVI) plays a pivotal role in assessing the underlying mechanisms and guiding treatment decisions. The use of thrombus aspiration and intracoronary antithrombotic therapies have been debated in the context of de novo acute myocardial infarction, but they could have a remarkable role for ST. However, the optimal management of ST requires individualized approaches tailored to patient-specific factors. This review provides a comprehensive analysis of the current understanding of ST, encompassing its incidence, outcomes, and risk factors, focusing on procedural acute management.","PeriodicalId":509663,"journal":{"name":"Vessel Plus","volume":" 1221","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140988932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Vessel PlusPub Date : 2024-01-24DOI: 10.20517/2574-1209.2023.122
Ramon A. Riojas, Jennifer S Lawton, Thomas S. Metkus Jr.
{"title":"The heart team: the multidisciplinary approach to coronary artery disease","authors":"Ramon A. Riojas, Jennifer S Lawton, Thomas S. Metkus Jr.","doi":"10.20517/2574-1209.2023.122","DOIUrl":"https://doi.org/10.20517/2574-1209.2023.122","url":null,"abstract":"The recommendation to employ a heart team to guide revascularization has persisted for over a decade. Despite evidence for improved adherence to guidelines, widespread adoption of the heart team approach has been limited. This review delves into the history of the guidelines endorsing the use of a heart team and the supporting data. Additionally, it outlines some attributes of a successful heart team, and how the heart team has been run at several large academic centers. Finally, it reviews some of the barriers to a heart team and future considerations.","PeriodicalId":509663,"journal":{"name":"Vessel Plus","volume":"1 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139601408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Vessel PlusPub Date : 2024-01-23DOI: 10.20517/2574-1209.2023.99
Maharshi Raval, Paul C. Gordon
{"title":"Evaluation and management of coronary artery disease in patients undergoing transcatheter aortic valve implantation","authors":"Maharshi Raval, Paul C. Gordon","doi":"10.20517/2574-1209.2023.99","DOIUrl":"https://doi.org/10.20517/2574-1209.2023.99","url":null,"abstract":"Significant coronary artery disease (CAD) and severe aortic stenosis (AS) are frequent findings in patients who undergo transcatheter aortic valve implantation (TAVI). With the extension of TAVI in patients who have intermediate and even low surgical risk, the optimal evaluation and management of concomitant CAD needs to be determined. Both pre-TAVI evaluation of CAD and indications for revascularization remain a matter of debate. In this review, we provide an updated overview of the prevailing landscape of CAD in patients undergoing TAVI with a focus on its prognostic impact, diagnostic evaluation pre-procedure, indications for revascularization, optimal timing of revascularization, and future directions.","PeriodicalId":509663,"journal":{"name":"Vessel Plus","volume":"126 11","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139604892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Vessel PlusPub Date : 2024-01-22DOI: 10.20517/2574-1209.2023.55
Lauren E. Levy, Megan Zak, Jason P. Glotzbach
{"title":"Current understanding of the genetics of thoracic aortic disease","authors":"Lauren E. Levy, Megan Zak, Jason P. Glotzbach","doi":"10.20517/2574-1209.2023.55","DOIUrl":"https://doi.org/10.20517/2574-1209.2023.55","url":null,"abstract":"Thoracic aortic dissection is a feared, highly lethal condition most commonly developing from aneurysmal dilation of the thoracic aorta. Elective prophylactic replacement of thoracic aortic aneurysms dramatically mitigates this risk. However, diagnosis of a thoracic aortic aneurysm can be challenging. Thoracic aortic disease - horacic aortic aneurysm and dissection (TAAD) - can be sporadic or heritable. Patients with syndromic heritable TAAD present with classic phenotype and clinical features correlating to their disease. In contrast, patients with non-syndromic heritable disease are harder to diagnose due to their lack of defining uniform phenotypes. Recent advances in genomics have begun to elucidate the genetic underpinnings of non-syndromic TAAD (ns-TAAD) for better understanding this complex disease and improve diagnosis and management. Herein, we review the foundation of knowledge in ns-TAAD heritability and key research studies identifying gene mutations in vascular smooth muscle cells, the extracellular matrix, and TGF-beta signaling present in ns-TAAD. We summarize the current guidelines for the diagnosis, screening, and surgical management of ns-TAAD including recommendations for genetic testing of high-risk individuals. Finally, we highlight areas of future research that will continue to advance our understanding of the complex genetic and epigenetic factors in TAAD.","PeriodicalId":509663,"journal":{"name":"Vessel Plus","volume":"28 23","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139607840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Vessel PlusPub Date : 2024-01-12DOI: 10.20517/2574-1209.2023.90
Christine Ashenhurst, Omar Toubar, Ming Hao Guo, Hugo Issa, Menaka Ponnambalam, Marc Ruel
{"title":"Early and long-term outcomes of less invasive approaches to coronary artery bypass surgery","authors":"Christine Ashenhurst, Omar Toubar, Ming Hao Guo, Hugo Issa, Menaka Ponnambalam, Marc Ruel","doi":"10.20517/2574-1209.2023.90","DOIUrl":"https://doi.org/10.20517/2574-1209.2023.90","url":null,"abstract":"This review outlines the development of less invasive treatments for coronary artery disease, focusing primarily on minimally invasive coronary artery bypass grafting (MICS CABG). We compare conventional coronary artery bypass grafting (CABG) and MICS CABG indications and contraindications, surgical techniques, early and long-term outcomes, and the process of implementation of MICS CABG to cardiac surgery programs. The invasiveness of cardiopulmonary bypass and the sternotomy incision used in conventional CABG are appreciably mitigated by the MICS CABG procedure, which is generally performed off-pump and through a left mini-thoracotomy. In the literature, MICS CABG is a feasible alternative to sternotomy CABG with safe, reproducible, efficient, and durable outcomes.","PeriodicalId":509663,"journal":{"name":"Vessel Plus","volume":"13 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139532787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Vessel PlusPub Date : 2024-01-12DOI: 10.20517/2574-1209.2023.95
Sharif A. Sabe, D. Harris, M. Broadwin, Cynthia M Xu, Mohamed Sabra, D. Banerjee, M. Abid, Frank W. Sellke
{"title":"Comparative effects of canagliflozin and sitagliptin in chronically ischemic myocardium","authors":"Sharif A. Sabe, D. Harris, M. Broadwin, Cynthia M Xu, Mohamed Sabra, D. Banerjee, M. Abid, Frank W. Sellke","doi":"10.20517/2574-1209.2023.95","DOIUrl":"https://doi.org/10.20517/2574-1209.2023.95","url":null,"abstract":"Aim: Recent studies demonstrate that sodium-glucose cotransporter 2 inhibitors (SGLT2i) and dipeptidyl peptidase-4 inhibitors (DPP4i), two classes of antidiabetic drugs, are cardioprotective. However, the mechanisms of these benefits and their comparative efficacy remain unclear. We aimed to compare the effects of these antidiabetic agents on cardiac function, perfusion, and microvascular density using a swine model of chronic myocardial ischemia.\u0000 Methods: Chronic myocardial ischemia was induced in Yorkshire swine by ameroid constrictor placement to the left circumflex artery. Two weeks later, pigs were administered vehicle (“CON”, 8 pigs), 300 mg SGLT2i canagliflozin, (“CANA”, 8 pigs), or 100 mg DPP4i sitagliptin (“SIT”, 5 pigs) daily. Five weeks later, pigs were euthanized. Cardiac function, perfusion, collateralization, and protein expression were determined by pressure-volume catheter, microsphere analysis, immunofluorescence, and immunoblotting, respectively.\u0000 Results: Compared with SIT, CANA was associated with improved stroke volume and cardiac output, with a trend towards reduced left ventricular stiffness. Both CANA and SIT trended towards improved perfusion compared to CON, but there were no differences between the two treatment groups. SIT was associated with improved capillary density with a trend towards improved arteriolar density compared to CANA. Both CANA and SIT were associated with increased expression of vascular endothelial cadherin compared to CON, without differences in treatment groups. SIT pigs had decreased 5′ adenosine monophosphate-activated protein kinase activation compared to CON and CANA. There was a trend towards increased endothelial nitric oxide synthase activation in the SIT group compared to CON. There were no differences in activation of extracellular signal-regulated kinase 1/2 across groups.\u0000 Conclusions: In the setting of chronic myocardial ischemia, canagliflozin is associated with improved cardiac function compared to sitagliptin, with similar effects on perfusion despite differences in microvascular collateralization.","PeriodicalId":509663,"journal":{"name":"Vessel Plus","volume":"53 30","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139532833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}